Security Snapshot

Alto Ingredients, Inc. - Common Stock (ALTO) Institutional Ownership

CUSIP: 021513106

13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

132

Shares (Excl. Options)

35,903,079

Price

$5.70

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,425,777
Value change
+$25,062,589
Number of holders
132
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
77,668,101
SEC-reported price per share
$4.86
Insider filing price
$4.86
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ALTO - Alto Ingredients, Inc. - Common Stock is tracked under CUSIP 021513106.
  • 132 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 101 to 132 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $155,704,619 to $204,550,977.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 132 institutions filings for Q2 2026.

Open SEC evidence

Security key

021513106

Latest holder period

Q2 2026

13F holders

132

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
ALTO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.9% $30,546,864 5,359,099 BlackRock, Inc. 30 Jun 2026
Radoff Bradley Louis 4.7% 0% $3,226,250 3,625,000 0% Radoff Bradley Louis 17 Mar 2025
DOMO Capital Management, LLC 3.4% -53% $6,753,576 -$7,013,400 2,658,888 -51% DOMO Capital Management, LLC 31 Dec 2025

As of 30 Jun 2026, 132 institutional investors reported holding 35,903,079 shares of Alto Ingredients, Inc. - Common Stock (ALTO). This represents 46% of the company’s total 77,668,101 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.1% 5,495,025 +323% 0% $31,321,643
VANGUARD CAPITAL MANAGEMENT LLC 4.1% 3,212,643 +1% 0% $18,312,065
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 2.9% 2,280,128 +27% 0.01% $12,996,730
ACADIAN ASSET MANAGEMENT LLC 2.6% 2,048,492 +247% 0.01% $11,662,000
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,980,080 +122% 0% $11,289,288
Hillsdale Investment Management Inc. 2.2% 1,703,703 +70% 0.22% $9,711,108
RENAISSANCE TECHNOLOGIES LLC 2% 1,518,521 -9.3% 0.01% $8,655,570
STATE STREET CORP 1.6% 1,230,173 +230% 0% $7,011,986
TWO SIGMA INVESTMENTS, LP 1.5% 1,198,890 -40% 0.01% $6,833,673
DIMENSIONAL FUND ADVISORS LP 1.5% 1,143,740 +73% 0% $6,517,591
Connor, Clark & Lunn Investment Management Ltd. 1.1% 855,702 +122% 0.01% $4,877,502
JACOBS LEVY EQUITY MANAGEMENT, INC 1.1% 827,481 +333% 0.02% $4,716,642
NORTHERN TRUST CORP 1% 784,047 +276% 0% $4,469,068
CREATIVE FINANCIAL DESIGNS INC /ADV 0.79% 615,304 -20% 0.17% $3,507,233
PANAGORA ASSET MANAGEMENT INC 0.75% 583,829 0.01% $3,327,825
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 574,674 +213% 0% $3,275,642
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.67% 520,314 +6.6% 0.05% $2,965,790
VANGUARD FIDUCIARY TRUST CO 0.65% 508,017 +7.1% 0% $2,895,697
VANGUARD PORTFOLIO MANAGEMENT LLC 0.64% 497,008 0% $2,832,946
GOLDMAN SACHS GROUP INC 0.63% 490,240 -19% 0% $2,794,368
BNP PARIBAS FINANCIAL MARKETS 0.62% 479,586 0% 0% $2,733,640
ALGERT GLOBAL LLC 0.61% 477,169 +295% 0.03% $2,719,863
Empowered Funds, LLC 0.57% 443,314 +7.8% 0.01% $2,526,890
LPL Financial LLC 0.44% 343,060 +1800% 0% $1,955,442
Bank of New York Mellon Corp 0.41% 314,862 +3025% 0% $1,794,715

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 35,903,079 $204,550,977 +$25,062,589 $5.70 132
2026 Q1 32,207,581 $155,704,619 +$50,786,725 $4.84 101
2025 Q4 22,043,969 $63,487,792 +$20,124,767 $2.88 84
2025 Q3 15,792,259 $17,054,175 -$1,392,369 $1.08 63
2025 Q2 17,029,028 $19,583,894 -$2,618,310 $1.15 61
2025 Q1 19,318,275 $22,022,488 -$3,332,534 $1.14 64
2024 Q4 21,761,778 $33,949,743 -$2,254,651 $1.56 74
2024 Q3 22,263,352 $35,843,066 -$4,826,303 $1.61 76
2024 Q2 25,745,558 $37,201,513 -$7,106,301 $1.44 79
2024 Q1 29,745,536 $64,842,219 -$7,340,042 $2.18 101
2023 Q4 32,605,314 $86,728,090 +$8,688,130 $2.66 101
2023 Q3 28,271,054 $124,957,461 +$8,269,534 $4.42 104
2023 Q2 26,957,003 $77,902,158 -$25,949,134 $2.89 96
2023 Q1 38,572,959 $57,860,079 -$5,727,335 $1.50 103
2022 Q4 40,024,501 $115,266,300 +$2,094,303 $2.88 124
2022 Q3 38,753,897 $141,070,744 -$26,771,975 $3.64 127
2022 Q2 45,730,439 $169,651,023 +$4,825,309 $3.71 113
2022 Q1 42,281,960 $286,180,985 +$14,467,736 $6.82 127
2021 Q4 42,445,149 $204,181,317 -$17,504,703 $4.81 109
2021 Q3 41,133,427 $207,802,804 -$9,420,016 $4.94 106
2021 Q2 43,375,750 $268,203,133 +$14,772,097 $6.11 112
2021 Q1 41,519,269 $225,683,755 +$217,479,006 $5.43 88
2020 Q4 1,406,314 $7,635,961 +$7,635,961 $5.43 5
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .